JP2024543457A5 - - Google Patents
Info
- Publication number
- JP2024543457A5 JP2024543457A5 JP2024527771A JP2024527771A JP2024543457A5 JP 2024543457 A5 JP2024543457 A5 JP 2024543457A5 JP 2024527771 A JP2024527771 A JP 2024527771A JP 2024527771 A JP2024527771 A JP 2024527771A JP 2024543457 A5 JP2024543457 A5 JP 2024543457A5
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- composition according
- approximately
- insulin
- efsitora
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163279390P | 2021-11-15 | 2021-11-15 | |
| US63/279,390 | 2021-11-15 | ||
| PCT/US2022/079791 WO2023086980A1 (en) | 2021-11-15 | 2022-11-14 | Preserved formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543457A JP2024543457A (ja) | 2024-11-21 |
| JP2024543457A5 true JP2024543457A5 (https=) | 2025-04-04 |
Family
ID=84537390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527771A Pending JP2024543457A (ja) | 2021-11-15 | 2022-11-14 | 保存製剤 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20250000950A1 (https=) |
| EP (1) | EP4433024A1 (https=) |
| JP (1) | JP2024543457A (https=) |
| KR (1) | KR20240082407A (https=) |
| CN (1) | CN118302152A (https=) |
| AR (1) | AR127619A1 (https=) |
| AU (1) | AU2022386352B2 (https=) |
| CA (1) | CA3238180A1 (https=) |
| CL (1) | CL2024001415A1 (https=) |
| CO (1) | CO2024006121A2 (https=) |
| CR (1) | CR20240202A (https=) |
| DO (1) | DOP2024000084A (https=) |
| EC (1) | ECSP24036789A (https=) |
| IL (1) | IL312623A (https=) |
| JO (1) | JOP20240108A1 (https=) |
| MX (1) | MX2024005879A (https=) |
| PE (1) | PE20241354A1 (https=) |
| TW (1) | TWI871539B (https=) |
| WO (1) | WO2023086980A1 (https=) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8097584B2 (en) * | 2005-05-25 | 2012-01-17 | Novo Nordisk A/S | Stabilized formulations of insulin that comprise ethylenediamine |
| AR081066A1 (es) | 2010-04-02 | 2012-06-06 | Hanmi Holdings Co Ltd | Conjugado de insulina donde se usa un fragmento de inmunoglobulina |
| US20130011378A1 (en) * | 2011-06-17 | 2013-01-10 | Tzung-Horng Yang | Stable formulations of a hyaluronan-degrading enzyme |
| CN103509118B (zh) | 2012-06-15 | 2016-03-23 | 郭怀祖 | 胰岛素-Fc融合蛋白 |
| AR091902A1 (es) * | 2012-07-25 | 2015-03-11 | Hanmi Pharm Ind Co Ltd | Formulacion liquida de un conjugado de insulina de accion prolongada |
| AR105616A1 (es) * | 2015-05-07 | 2017-10-25 | Lilly Co Eli | Proteínas de fusión |
| JP2020513019A (ja) | 2017-04-05 | 2020-04-30 | ノヴォ ノルディスク アー／エス | オリゴマー伸長インスリン−Ｆｃコンジュゲート |
| KR20210029210A (ko) | 2018-06-29 | 2021-03-15 | 악스톤 바이오사이언시스 코퍼레이션 | 초장기 작용 인슐린-fc 융합 단백질 및 사용 방법 |
| WO2020074544A1 (en) | 2018-10-10 | 2020-04-16 | Novo Nordisk A/S | Oligomer extended insulin-fc conjugates and their medical use |
| US20220354782A1 (en) * | 2019-09-17 | 2022-11-10 | Cass Pharmaceuticals, Inc. | Subcutaneously injectable insulin and glucagon formulations and methods of administration |
| WO2021119607A1 (en) * | 2019-12-13 | 2021-06-17 | The Board Of Trustees Of The Leland Stanford Junior University | Stable monomeric insulin formulations enabled by supramolecular pegylation of insulin analogues |
| KR20250142943A (ko) | 2019-12-19 | 2025-09-30 | 악스톤 바이오사이언시스 코퍼레이션 | 초-장기 작용 인슐린-fc 융합 단백질 및 사용 방법 |
| US11186623B2 (en) | 2019-12-24 | 2021-11-30 | Akston Bioscience Corporation | Ultra-long acting insulin-Fc fusion proteins and methods of use |
| US11192930B2 (en) | 2020-04-10 | 2021-12-07 | Askton Bioscences Corporation | Ultra-long acting insulin-Fc fusion protein and methods of use |
| US11198719B2 (en) | 2020-04-29 | 2021-12-14 | Akston Biosciences Corporation | Ultra-long acting insulin-Fc fusion protein and methods of use |
-
2022
- 2022-11-09 TW TW111142719A patent/TWI871539B/zh active
- 2022-11-09 AR ARP220103074A patent/AR127619A1/es unknown
- 2022-11-14 PE PE2024001075A patent/PE20241354A1/es unknown
- 2022-11-14 CA CA3238180A patent/CA3238180A1/en active Pending
- 2022-11-14 US US18/709,721 patent/US20250000950A1/en active Pending
- 2022-11-14 IL IL312623A patent/IL312623A/en unknown
- 2022-11-14 CN CN202280075570.XA patent/CN118302152A/zh active Pending
- 2022-11-14 JP JP2024527771A patent/JP2024543457A/ja active Pending
- 2022-11-14 CR CR20240202A patent/CR20240202A/es unknown
- 2022-11-14 KR KR1020247015596A patent/KR20240082407A/ko active Pending
- 2022-11-14 EP EP22826289.5A patent/EP4433024A1/en active Pending
- 2022-11-14 AU AU2022386352A patent/AU2022386352B2/en active Active
- 2022-11-14 WO PCT/US2022/079791 patent/WO2023086980A1/en not_active Ceased
- 2022-11-14 MX MX2024005879A patent/MX2024005879A/es unknown
-
2024
- 2024-05-10 CL CL2024001415A patent/CL2024001415A1/es unknown
- 2024-05-13 DO DO2024000084A patent/DOP2024000084A/es unknown
- 2024-05-14 JO JOJO/P/2024/0108A patent/JOP20240108A1/ar unknown
- 2024-05-15 EC ECSENADI202436789A patent/ECSP24036789A/es unknown
- 2024-05-15 CO CONC2024/0006121A patent/CO2024006121A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018138578A5 (https=) | ||
| JP7159277B2 (ja) | 即効型インスリン組成物 | |
| JP7150804B2 (ja) | プラミノーゲンを含む医薬組成物及びその使用 | |
| US7879805B2 (en) | High temperature stable peptide formulation | |
| AR026355A1 (es) | Formulacion y metodo antidiabetico. | |
| US7540382B2 (en) | Stabilized liquid protein formulations in pharmaceutical containers | |
| Houang et al. | Cardiac muscle membrane stabilization in myocardial reperfusion injury | |
| KR20140146209A (ko) | 인슐린 및 인슐린 유사체의 약동학 및 약역학과 주사 통증을 조절하기 위한 마그네슘 조성물 | |
| JP2018504420A5 (https=) | ||
| HU227951B1 (en) | Oil in water emulsions containing propofol and disodium edetate | |
| US9636376B2 (en) | Stable compositions of peptide epoxy ketones | |
| EP3156071A1 (en) | Stable aqueous adalimumab preparation | |
| CA3019748C (en) | Ophthalmic composition comprising pvp-i | |
| JP5859987B2 (ja) | タンパク質製剤 | |
| JP2021532110A5 (https=) | ||
| US20100144597A1 (en) | Novel combinatorial approaches to enhancing oxygen transport to tissues | |
| JP2024543457A5 (https=) | ||
| EP2804597B1 (en) | Aqueous paracetamol composition for injection | |
| CN104888196A (zh) | 一种稳定的干扰素α多剂量笔注射液 | |
| JP2008120798A (ja) | ヘパリン製剤 | |
| IL312623A (en) | Preserved formulations | |
| ES2727257T3 (es) | Administración intravesical de apaziquona después de la resección transuretral para el tratamiento del cáncer de vejiga | |
| EP3897571A1 (en) | Novel composition | |
| JP4252260B2 (ja) | Ｐｔｈの安定化水溶液注射剤 | |
| RU2564951C1 (ru) | Композиция водного раствора рекомбинантного интерферона альфа-2 человека для ректального применения |